Literature DB >> 20674420

Time to abandon the term angiomyolipoma for non-PEComatous angiomyomatous (or angiomatous) oral tumors with adipocytes.

Konstantinos I Tosios1, Ioannis G Koutlas, Vasileios F Kyriakopoulos, Maria Balta, Nandia Theologie-Lygidakis, Emmanuel Vardas, Ioannis Iatrou.   

Abstract

Angiomyolipoma (AML) is the most common benign mesenchymal neoplasm of the kidneys with well-established clinical and morphological features. The oral and maxillofacial pathology literature contains several examples that identify angiomyomatous proliferations of the oral mucosa that contain an adipocytic component as analogous to classic renal AMLs although they differ significantly in their immunohistochemical phenotype. Herein, through review of the pertinent oral pathology literature and the detailed description of 2 lesions, one an oral angiomyoma with an adipocytic component and the other an apparently hamartomatous angioleiomyomatous proliferation with adipocytes, we provide, in our opinion, a solid argument against the use of the term AML for non-PEComatous oral tumors.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674420     DOI: 10.1016/j.tripleo.2010.04.045

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  2 in total

Review 1.  PEComa of the nose: report of a case with immunohistochemical and ultrustructural studies and a review of the literature.

Authors:  Amir Afrogheh; Johann Schneider; Abraham Fourie Bezuidenhout; Jos Hille
Journal:  Head Neck Pathol       Date:  2013-07-10

2.  Nasal Angiomyolipoma (AML) Mimicking Juvenile Nasopharyngeal Angiofibroma.

Authors:  Saiful-Azhar Ameen; Husain Salina; Farah-Dayana Zahedi; Sabir-Husin-Athar Primuharsa-Putra; Noraidah Masir
Journal:  Iran J Otorhinolaryngol       Date:  2019-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.